About
Bruce J. Kinon, MD, affiliated with Karuna Therapeutics in Boston, Massachusetts, has published extensively on schizophrenia and schizoaffective disorders, focusing on antipsychotic treatment mechanisms, medication adherence, and weight-related health factors. His work also addresses genetic determinants of antipsychotic response and the clinical evaluation of novel therapeutic strategies. Kinon's research spans psychiatry, neurology, and sexual dysfunction, contributing to the understanding of treatment outcomes and clinical trial design in schizophrenia.
